Outlook Therapeutics Inc (OTLK)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Outlook Therapeutics Inc Azioni (OTLK) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	1,248% -1.2375	-0.0918	1.5053	-0.0185	0.0489
Cost Of Revenue	96.77% 0.0296	0.9165	0.4398	-	-
Gross Profit	22.73% -1.2375	-1.0083	1.0655	-	-
Operating Expenses	24.90% 12.25	16.31	16.81	12.37	21.66
Benefits Costs and Expenses	47.88% 21.82	14.76	21.66	46.34	-17.33
Costs And Expenses	17.00% 12.25	14.76	21.66	46.34	-17.33
Depreciation and Amortization	1.13% 0.0301	0.0297	0.0294	-	-
Operating Income/Loss	22.12% -13.48	-17.31	-15.75	-12.39	-21.61
Net Interest Income/Expense	100.00% -	-0.2642	-0.0494	-0.0185	0.0489
Income/Loss Before Equity Method Investments	55.46% -23.02	-14.81	-20.12	-46.32	17.41
Income/Loss From Equity Method Investments	4.42% -0.0386	-0.0404	-0.0309	-0.0364	-0.0333
Income/Loss From Continuing Operations Before Tax	55.30% -23.06	-14.85	-20.15	-46.35	17.38
Income/Loss From Continuing Operations After Tax	73.46% -23.06	-13.29	-20.15	-46.36	17.38
Net Income/Loss	73.46% -23.06	-13.29	-20.15	-46.36	17.38
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,357% 60.21	4.1321	36.96	30.87	-3.3567
Diluted Average Shares	1,357% 60.21	4.1321	36.96	30.87	-3.3567
Basic Earnings Per Share	100.00% -0.38	-0.19	-0.55	-1.50	0.45
Diluted Earnings Per Share	100.00% -0.38	-0.19	-0.55	-1.50	0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%